TY  - GEN
N2  - Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States, causing more than 37,000 cases of cancer each year; over 90% of these cancers could be prevented with the HPV vaccine. In 2019, The CDC's Advisory Committee on Immunization Practices (ACIP) recommended catch-up vaccination to all adults up to age 26. For adults aged 27-45 (mid-adult), the ACIP advised providers to engage patients in shared clinical decision-making (SCDM) conversations about the vaccine while considering an individual patient's needs and lifestyle.    This study aimed to find what percentage of licensed nurse practitioners (NPs) in Oregon were aware of the vaccine's expanded age approval, how often those NPs were discussing the vaccine with their mid-adult patients, and what barriers exist that prevent NPs from engaging in SCDM conversations around HPV vaccination with their mid-adult patients. To achieve these aims, an online survey was developed and distributed to 1,081 NPs in Oregon. Data from 147 completed surveys were used to answer the research questions.
DO  - 10.6083/0r967463k
DO  - DOI
AB  - Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States, causing more than 37,000 cases of cancer each year; over 90% of these cancers could be prevented with the HPV vaccine. In 2019, The CDC's Advisory Committee on Immunization Practices (ACIP) recommended catch-up vaccination to all adults up to age 26. For adults aged 27-45 (mid-adult), the ACIP advised providers to engage patients in shared clinical decision-making (SCDM) conversations about the vaccine while considering an individual patient's needs and lifestyle.    This study aimed to find what percentage of licensed nurse practitioners (NPs) in Oregon were aware of the vaccine's expanded age approval, how often those NPs were discussing the vaccine with their mid-adult patients, and what barriers exist that prevent NPs from engaging in SCDM conversations around HPV vaccination with their mid-adult patients. To achieve these aims, an online survey was developed and distributed to 1,081 NPs in Oregon. Data from 147 completed surveys were used to answer the research questions.
AD  - Oregon Health and Science University
T1  - Let's talk about it: shared clinical decision-making around HPV vaccination in mid-adults
DA  - 2023
AU  - Martin, Whitney
L1  - https://digitalcollections.ohsu.edu/record/10028/files/Martin.Whitney.2023.pdf
PB  - Oregon Health and Science University
PY  - 2023
ID  - 10028
L4  - https://digitalcollections.ohsu.edu/record/10028/files/Martin.Whitney.2023.pdf
KW  - Immunization
KW  - Adult
KW  - Human Papillomavirus Viruses
KW  - Papillomavirus Vaccines
KW  - Clinical Decision-Making
KW  - HPV vaccines
TI  - Let's talk about it: shared clinical decision-making around HPV vaccination in mid-adults
Y1  - 2023
L2  - https://digitalcollections.ohsu.edu/record/10028/files/Martin.Whitney.2023.pdf
LK  - https://digitalcollections.ohsu.edu/record/10028/files/Martin.Whitney.2023.pdf
UR  - https://digitalcollections.ohsu.edu/record/10028/files/Martin.Whitney.2023.pdf
ER  -